Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-11

Clinical Trial Update: Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating widefield angiography-guided targeted-retinal photocoagulation with anti-VEGF injections for ischemic central, hemi-, and branch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • anti-VEGF (vascular endothelial growth factor inhibitor)

Snippet

Sponsor: Charles C Wykoff, PhD, MD | Conditions: Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions | Phase 4 | Status: COMPLETED | Results posted: 2017-04-11